Welcome to our dedicated page for CINTAS SEC filings (Ticker: CTAS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cintas Corporation filings document the formal disclosures of a Nasdaq-listed uniform and facility-services company, including operating results, material definitive agreements, financing arrangements, governance matters and shareholder votes. Recent Form 8-K reports cover quarterly financial results, a revolving credit facility and other material agreements, while annual meeting filings record director elections, advisory executive-compensation votes, auditor ratification and shareholder voting outcomes.
The company’s proxy materials describe board structure, executive compensation, equity awards, audit matters and shareholder voting procedures. Cintas filings also disclose capital-structure and liquidity terms, including subsidiary guarantees, covenants, letter-of-credit and swing-line mechanics, and other governance subjects tied to its route-based uniform, facility services, first aid and safety, and fire protection operations.
Cintas Corp. (CTAS) filed a Form 144 indicating an insider’s intent to sell up to 5,084 common shares through broker Fifth Third Securities on or after 30 Jul 2025 via NASDAQ. The proposed sale carries an aggregate market value of $1.132 million and represents roughly 0.0013 % of the company’s 403.8 million shares outstanding.
The shares were originally acquired as a stock award on 17 Oct 2014. The filer reports no other sales in the past three months. Form 144 is a notice only; execution is not guaranteed, and no new operational or financial information was disclosed.
Cintas Corp. (CTAS) Form 144 reveals a proposed insider sale of 17,301 common shares, about 0.004 % of the company’s 403.8 M shares outstanding. At the recent market price, the block is valued near $3.84 million. The shares were obtained the same day via a cash-settled stock-option exercise and will be sold through Fidelity Brokerage Services on or around 28 Jul 2025 on Nasdaq. No other insider sales during the past three months are reported, and the filer attests to possessing no undisclosed adverse information.